Skip to content

TG Therapeutics

US · TGTX #1638 by market cap Listed 1970
52.95 +0.76 +1.46%
Live - 5344 symbols - heartbeat 252s ago · 2026-10-08 08:09
Pre-market 52.85 -0.19%
After-hours 53.18 +0.43%
Market cap
8.11B
P/B
13.42
EPS
2.77
Reader sentiment Are you bullish or bearish on TGTX?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    TD Cowen Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $75
    Market Newswire · 2026/8/4
  • H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $78
    Market Newswire · 2026/9/22
  • J.P. Morgan Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $72
    Market Newswire · 2026/8/11
  • B. Riley Securities Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $86
    Market Newswire · 2026/9/2
  • Rating change
    Goldman Sachs Maintains TG Therapeutics(TGTX.US) With Hold Rating, Raises Target Price to $41
    Market Newswire · 2026/5/28
  • Rating change
    BofA Securities Maintains TG Therapeutics(TGTX.US) With Sell Rating, Raises Target Price to $17
    Market Newswire · 2026/6/4
  • Rating change
    H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $70
    Market Newswire · 2026/7/6
  • Rating change
    H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $78
    Market Newswire · 2026/8/4
  • Rating change
    Jefferies Maintains TG Therapeutics(TGTX.US) With Buy Rating, Maintains Target Price $83
    Market Newswire · 2026/7/14
  • Rating change
    J.P. Morgan Maintains TG Therapeutics(TGTX.US) With Buy Rating
    Market Newswire · 2026/5/28
  • Rating change
    TG Therapeutics (TGTX) Gets a Buy From H.C. Wainwright
    TipRanks · 2026/7/13
  • Rating change
    BofA Securities Maintains TG Therapeutics(TGTX.US) With Sell Rating, Raises Target Price to $21
    Market Newswire · 2026/8/5
  • Rating change
    TD Cowen Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $75
    Market Newswire · 2026/7/22
  • TG Therapeutics (TGTX) Receives a Buy From H.C. Wainwright
    TipRanks · 2026/9/22
  • Rating change
    Jefferies Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $83
    Market Newswire · 2026/6/23
  • Rating change
    Goldman Sachs Maintains TG Therapeutics(TGTX.US) With Hold Rating, Maintains Target Price $41
    Market Newswire · 2026/6/4
  • B. Riley Securities Remains a Buy on TG Therapeutics (TGTX)
    TipRanks · 2026/9/2
  • Rating change
    BofA Securities Maintains TG Therapeutics(TGTX.US) With Sell Rating, Raises Target Price to $20
    Market Newswire · 2026/7/7
  • Rating change
    H.C. Wainwright Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $77
    Market Newswire · 2026/7/13
  • Rating change
    J.P. Morgan Maintains TG Therapeutics(TGTX.US) With Buy Rating, Announces Target Price $65
    Market Newswire · 2026/7/16

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 08:09:24 · For reference only, not investment advice and not tailored to your situation.